AllPeptides.eu - Advanced Peptide Research
    Back to matrix
    Healing

    TB-500 (Thymosin β4)

    None of the 30 tracked EU+ jurisdictions lists TB-500 (Thymosin β4) as authorised. This page summarises approval status, brands, shortages and recent regulatory changes by country.

    Protocol detail references

    2mg5mg10mg20mg

    Related regulatory compounds

    BPC-157

    Country-by-country approval and availability

    30 EU+ jurisdictions covered.

    🇩🇪
    Germany

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    France

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇮🇹
    Italy

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇪🇸
    Spain

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇳🇱
    Netherlands

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇬🇷
    Greece

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇸🇪
    Sweden

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇩🇰
    Denmark

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇫🇮
    Finland

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇦🇹
    Austria

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇧🇪
    Belgium

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇱🇺
    Luxembourg

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇵🇹
    Portugal

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇮🇪
    Ireland

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇵🇱
    Poland

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇨🇿
    Czech Republic

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇸🇰
    Slovakia

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇭🇺
    Hungary

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇸🇮
    Slovenia

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇭🇷
    Croatia

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇪🇪
    Estonia

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇱🇻
    Latvia

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇱🇹
    Lithuania

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇷🇴
    Romania

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇧🇬
    Bulgaria

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇨🇾
    Cyprus

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇲🇹
    Malta

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇬🇧
    United Kingdom

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇨🇭
    Switzerland

    WADA prohibited substance; additional restrictions for athletes.

    Research only
    🇳🇴
    Norway

    WADA prohibited substance; additional restrictions for athletes.

    Research only

    Updates for TB-500 (Thymosin β4)

    • 2024-05-10 · 🇪🇺 EU

      WADA: TB-500 confirmed as prohibited substance

      WADA updated the 2024 list keeping thymosin β4 fragment as S2 anabolic agent.

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu

    Join on TelegramJoin on WhatsApp